Read Heron Therapeutics Inc. (AXD2.SG) Q4 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...

Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...

Earnings call Heron reported FY25 net product sales of $154.9M and adjusted EBITDA of $14.7M, exceeding guidance. Acute care revenues surged in Q4, with ZYNRELEF and APONVIE up 48% and 97% YoY, ...

Except as required by law, Heron assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so. And with that, I would now ...

Image source: The Motley Fool. Heron Therapeutics (NASDAQ:HRTX) delivered operational and financial milestones, including full-year adjusted EBITDA above guidance and net product revenue gains led by ...